C. M. Perou, T. Sørlie, M. B. Eisen, M. Van-de-rijn, S. S. Jeffrey et al., Molecular portraits of human breast tumours, Nature, vol.406, pp.747-752, 2000.

A. S. Coates, E. P. Winer, A. Goldhirsch, R. D. Gelber, M. Gnant et al., Panel Members: Tailoring therapies -improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer, vol.26, pp.1533-1546, 2015.

B. Zhang, J. Wang, X. Wang, J. Zhu, Q. Liu et al., NCI CPTAC: Proteogenomic characterization of human colon and rectal cancer, Nature, vol.513, pp.382-387, 2014.

H. J. Johansson, F. Socciarelli, N. M. Vacanti, M. H. Haugen, Y. Zhu et al.,

, Consortia Oslo Breast Cancer Research Consortium (OSBREAC): Breast cancer quantitative proteome and proteogenomic landscape, Nat Commun, vol.10, p.1600, 2019.

M. Mann, Quantitative proteomics, vol.17, pp.954-955, 1999.
URL : https://hal.archives-ouvertes.fr/hal-02492412

C. Monti, M. Zilocchi, C. I. Alberio, and T. , Proteomics turns functional, J Proteomics, vol.198, pp.36-44, 2019.

R. J. Simpson and D. S. Dorow, Cancer proteomics: From signaling networks to tumor markers, Trends Biotechnol, vol.19, pp.40-48, 2001.

C. Cheung and H. F. Juan, Quantitative proteomics in lung cancer, J Biomed Sci, vol.24, p.37, 2017.

T. Geiger and B. Geiger, Towards elucidation of functional molecular signatures of the adhesive-migratory phenotype of malignant cells, Semin Cancer Biol, vol.20, pp.146-152, 2010.

M. Jazurek, A. Ciesiolka, J. Starega-roslan, K. Bilinska, and W. J. Krzyzosiak, Identifying proteins that bind to specific RNAsfocus on simple repeat expansion diseases, Nucleic Acids Res, vol.44, pp.9050-9070, 2016.

N. Abazova and J. Krijgsveld, Advances in stem cell proteomics, Curr Opin Genet Dev, vol.46, pp.149-155, 2017.

C. G. Eubanks, G. Dayebgadoh, X. Liu, and M. P. Washburn, Unravelling the biology of chromatin in health and cancer using proteomic approaches, Expert Rev Proteomics, vol.14, pp.905-915, 2017.

M. Gómez-serrano, E. Camafeita, M. Loureiro, and B. Peral, Mitoproteomics: Tackling mitochondrial dysfunction in human disease, Oxid Med Cell Longev, p.1435934, 2018.

W. Suwakulsiri, A. Rai, M. Chen, D. W. Greening, and R. J. Simpson, Proteomic profiling reveals key cancer progression modulators in shed microvesicles released from isogenic human primary and metastatic colorectal cancer cell lines, Biochim Biophys Acta Proteins Proteom, vol.1867, p.140171, 2019.

Z. Li, N. Li, L. Shen, and J. Fu, Quantitative proteomic analysis identifies MAPK15 as a potential regulator of radioresistance in nasopharyngeal carcinoma cells, Front Oncol, vol.8, p.548, 2018.

L. Gillet, P. Navarro, S. Tate, H. Röst, N. Selevsek et al., Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis, Mol Cell Proteomics, vol.11, 2012.

C. Ludwig, L. Gillet, G. Rosenberger, S. Amon, C. Bc et al., Data-independent acquisition-based SWATH-MS for quantitative proteomics: A tutorial, Mol Syst Biol, vol.14, p.8126, 2018.

C. Krisp and M. P. Molloy, SWATH mass spectrometry for proteomics of non-depleted plasma, Methods Mol Biol, vol.1619, pp.373-383, 2017.

R. Jamwal, B. J. Barlock, S. Adusumalli, K. Ogasawara, B. L. Simons et al., Multiplex and label-free relative quantification approach for studying protein abundance of drug metabolizing enzymes in human liver microsomes using SWATH-MS

, J Proteome Res, vol.16, pp.4134-4143, 2017.

L. Wang, T. Skotland, V. Berge, K. Sandvig, and A. Llorente, Exosomal proteins as prostate cancer biomarkers in urine: From mass spectrometry discovery to immunoassay-based validation, Eur J Pharm Sci, vol.98, pp.80-85, 2017.

J. S. Nader, J. Abadie, S. Deshayes, A. Boissard, S. Blandin et al., Characterization of increasing stages of invasiveness identifies stromal/cancer cell crosstalk in rat models of mesothelioma, Oncotarget, vol.9, pp.16311-16329, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-01726393

D. Besson, A. Pavageau, I. Valo, A. Bourreau, A. Bélanger et al., A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor marker, Mol Cell Proteomics, vol.10, p.9712, 2011.

I. Valo, P. Raro, A. Boissard, A. Maarouf, P. Jézéquel et al., OLFM4 expression in ductal carcinoma in situ and in invasive breast cancer cohorts by a SWATH-based proteomic approach, Proteomics, vol.19, p.1800446, 2019.
URL : https://hal.archives-ouvertes.fr/inserm-02281345

A. A. Powell, A. H. Talasaz, H. Zhang, M. A. Coram, A. Reddy et al., Single cell profiling of circulating tumor cells: Transcriptional heterogeneity and diversity from breast cancer cell lines, PLoS One, vol.7, p.33788, 2012.

E. Lukanidin and J. P. Sleeman, Building the niche: The role of the S100 proteins in metastatic growth, Semin Cancer Biol, vol.22, pp.216-225, 2012.

A. R. Bresnick, D. J. Weber, and D. B. Zimmer, S100 proteins in cancer, Nat Rev Cancer, vol.15, pp.96-109, 2015.

F. Shabani, A. Farasat, M. Mahdavi, and N. Gheibi, Calprotectin (S100A8/S100A9): A key protein between inflammation and cancer, Inflamm Res, vol.67, pp.801-812, 2018.

P. Björk, E. Källberg, U. Wellmar, M. Riva, A. Olsson et al., Common interactions between S100A4 and S100A9 defined by a novel chemical probe, PLoS One, vol.8, p.63012, 2013.

F. Fei, J. Qu, M. Zhang, L. Y. Zhang, and S. , S100A4 in cancer progression and metastasis: A systematic review, Oncotarget, vol.8, pp.73219-73239, 2017.

H. Yoshimura, A. Otsuka, M. Michishita, M. Yamamoto, M. Ashizawa et al., Expression and roles of S100A4 in anaplastic cells of canine mammary carcinomas, Vet Pathol, vol.56, pp.389-398, 2019.

Y. Liu and X. Cao, Characteristics and significance of the pre-metastatic niche, Cancer Cell, vol.30, pp.668-681, 2016.

M. T. Hansen, B. Forst, N. Cremers, L. Quagliata, N. Ambartsumian et al., A link between inflammation and metastasis: Serum amyloid A1 and A3 induce metastasis, and are targets of metastasis-inducing S100A4, Oncogene, vol.34, pp.424-435, 2015.

M. Q. Mahmood, C. Ward, H. K. Muller, S. S. Sohal, and E. H. Walters, Epithelial mesenchymal transition (EMT) and non-small cell lung cancer (NSCLC): A mutual association with airway disease, Med Oncol, vol.34, p.45, 2017.

M. Liu, J. Liu, B. Yang, X. Gao, L. L. Gao et al., Inversed expression patterns of S100A4 and E-cadherin in cervical cancers: Implication in epithelial-mesenchymal transition, Anat Rec (Hoboken), vol.300, pp.2184-2191, 2017.

D. Roulois, S. Deshayes, M. N. Guilly, J. S. Nader, C. Liddell et al., Characterization of preneoplastic and neoplastic rat mesothelial cell lines: The involvement of TETs, DNMTs, and 5-hydroxymethylcytosine, Oncotarget, vol.7, pp.34664-34687, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-01306838

R. Donato, G. Sorci, and I. Giambanco, S100A6 protein: Functional roles, vol.74, pp.2749-2760, 2017.

X. Lyu, H. Li, X. Ma, X. Li, Y. Gao et al., High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma, Cell Biochem Biophys, vol.71, pp.279-290, 2015.

X. Luo, K. A. Sharff, J. Chen, T. He, and H. H. Luu, S100A6 expression and function in human osteosarcoma, Clin Orthop Relat Res, vol.466, pp.2060-2070, 2008.

J. Zhang, K. Zhang, X. Jiang, and J. Zhang, S100A6 as a potential serum prognostic biomarker and therapeutic target in gastric cancer, Dig Dis Sci, vol.59, pp.2136-2144, 2014.

S. J. Popa, S. E. Stewart, and K. Moreau, Unconventional secretion of annexins and galectins, Semin Cell Dev Biol, vol.83, pp.42-50, 2018.

V. Gerke, C. E. Creutz, and S. E. Moss, Annexins: Linking Ca 2+ signalling to membrane dynamics, Nat Rev Mol Cell Biol, vol.6, pp.449-461, 2005.

H. Qi, S. Liu, C. Guo, J. Wang, G. Ft et al., Role of annexin A6 in cancer (Review), vol.10, pp.1947-1952, 2015.

T. Grewal, M. Hoque, J. Conway, M. Reverter, M. Wahba et al., Annexin A6-A multifunctional scaffold in cell motility, Cell Adhes Migr, vol.11, pp.288-304, 2017.

A. M. Sakwe, R. Koumangoye, B. Guillory, and J. Ochieng, Annexin A6 contributes to the invasiveness of breast carcinoma cells by influencing the organization and localization of functional focal adhesions, Exp Cell Res, vol.317, pp.823-837, 2011.

I. Keklikoglou, C. Cianciaruso, E. Güç, M. L. Squadrito, L. M. Spring et al., Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models, Nat Cell Biol, vol.21, pp.190-202, 2019.

R. B. Koumangoye, G. N. Nangami, P. D. Thompson, V. K. Agboto, J. Ochieng et al., Reduced annexin A6 expression promotes the degradation of activated epidermal growth factor receptor and sensitizes invasive breast cancer cells to EGFR-targeted tyrosine kinase inhibitors, Mol Cancer, vol.12, p.167, 2013.

A. García-melero, M. Reverter, M. Hoque, E. Meneses-salas, M. Koese et al., Annexin A6 and late endosomal cholesterol modulate integrin recycling and cell migration, J Biol Chem, vol.291, pp.1320-1335, 2016.

S. E. Widatalla, O. Y. Korolkova, D. S. Whalen, J. S. Goodwin, K. P. Williams et al., Lapatinib-induced annexin A6 upregulation as an adaptive response of triple-negative breast cancer cells to EGFR tyrosine kinase inhibitors, Carcinogenesis, vol.40, pp.998-1009, 2019.

J. Leca, S. Martinez, S. Lac, J. Nigri, V. Secq et al., Cancer-associated fibroblast-derived annexin A6 + extracellular vesicles support pancreatic cancer aggressiveness, J Clin Invest, vol.126, pp.4140-4156, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01408056

D. S. Whalen, S. E. Widatalla, O. Y. Korolkova, G. S. Nangami, H. K. Beasley et al., Implication of calcium activated RasGRF2 in Annexin A6-mediated breast tumor cell growth and motility, Oncotarget, vol.10, pp.133-151, 2019.

M. H. Sheikh and E. Solito, Annexin A1: Uncovering the many talents of an old protein, Int J Mol Sci, vol.19, p.1045, 2018.

B. A. Babbin, W. Y. Lee, C. A. Parkos, L. M. Winfree, A. Akyildiz et al., Annexin I regulates SKCO-15 cell invasion by signaling through formyl peptide receptors, J Biol Chem, vol.281, 2006.

C. Guo, S. Liu, and M. Sun, Potential role of Anxa1 in cancer, Future Oncol, vol.9, pp.1773-1793, 2013.

H. Swa, A. A. Shaik, L. Lim, and J. Gunaratne, Mass spectrometry based quantitative proteomics and integrative network analysis accentuates modulating roles of annexin-1 in mammary tumorigenesis, Proteomics, vol.15, pp.408-418, 2015.

M. Okano, K. Kumamoto, M. Saito, H. Onozawa, K. Saito et al., Upregulated Annexin A1 promotes cellular invasion in triple-negative breast cancer, Oncol Rep, vol.33, pp.1064-1070, 2015.

Y. Tu, C. N. Johnstone, and A. G. Stewart, Annexin A1 influences in breast cancer: Controversies on contributions to tumour, host and immunoediting processes, Pharmacol Res, vol.119, pp.278-288, 2017.

S. Liao, X. Zhao, Y. Han, J. Zhang, L. Wang et al., Proteomics-based identification of two novel direct targets of hypoxia-inducible factor-1 and their potential roles in migration/invasion of cancer cells, Proteomics, vol.9, pp.3901-3912, 2009.

Y. Xu, J. Wang, Y. Xu, H. Xiao, L. J. Wang et al., Screening critical genes associated with malignant glioma using bioinformatics analysis, Mol Med Rep, vol.16, pp.6580-6589, 2017.

H. Kang, J. Ko, and S. Jang, The role of annexin A1 in expression of matrix metalloproteinase-9 and invasion of breast cancer cells, Biochem Biophys Res Commun, vol.423, pp.188-194, 2012.

A. K. Grindheim, J. Saraste, and A. Vedeler, Protein phosphorylation and its role in the regulation of Annexin A2 function, Biochim Biophys Acta, vol.1861, pp.2515-2529, 2017.

M. V. Christensen, C. K. Høgdall, K. M. Jochumsen, and E. Høgdall, Annexin A2 and cancer: A systematic review, Int J Oncol, vol.52, pp.5-18, 2018.

F. Maule, S. Bresolin, E. Rampazzo, D. Boso, D. Puppa et al., Annexin 2A sustains glioblastoma cell dissemination and proliferation, Oncotarget, vol.7, pp.54632-54649, 2016.

Y. Liu, H. Li, Z. Ban, M. Nai, L. Yang et al., Annexin A2 inhibition suppresses ovarian cancer progression via regulating ?-catenin/EMT, Oncol Rep, vol.37, pp.3643-3650, 2017.

M. R. Rocha, P. Barcellos-de-souza, A. Sousa-squiavinato, P. V. Fernandes, I. M. De-oliveira et al., Annexin A2 overexpression associates with colorectal cancer invasiveness and TGF-? induced epithelial mesenchymal transition via Src/ANXA2/STAT3, Sci Rep, vol.8, p.11285, 2018.

N. Yoneura, S. Takano, H. Yoshitomi, Y. Nakata, R. Shimazaki et al., Expression of annexin II and stromal tenascin C promotes epithelial to mesenchymal transition and correlates with distant metastasis in pancreatic cancer, Int J Mol Med, vol.42, pp.821-830, 2018.

Q. Zhang, Z. Zhao, Y. Ma, H. Wang, J. Ma et al., Combined expression of S100A4 and Annexin A2 predicts disease progression and overall survival in patients with urothelial carcinoma, Urol Oncol, vol.32, pp.798-805, 2014.

Q. Zhang, Z. Ye, Q. Yang, X. He, W. H. Zhao et al., Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer, World J Surg Oncol, vol.10, p.103, 2012.

A. M. Korwar, H. S. Bhonsle, A. D. Chougale, S. S. Kote, K. R. Gawai et al., Analysis of AGE modified proteins and RAGE expression in HER2/neu negative invasive ductal carcinoma, Biochem Biophys Res Commun, vol.419, pp.490-494, 2012.

S. H. Sheng and H. L. Zhu, Proteomic analysis of pleural effusion from lung adenocarcinoma patients by shotgun strategy, Clin Transl Oncol, vol.16, pp.153-157, 2014.

C. Ricciardelli, N. A. Lokman, M. P. Ween, and M. K. Oehler, WOMEN IN CANCER THEMATIC REVIEW: Ovarian cancer-peritoneal cell interactions promote extracellular matrix processing, Endocr Relat Cancer, vol.23, pp.155-168, 2016.

F. A. Van-den-brûle, C. Buicu, A. Berchuck, R. C. Bast, M. Deprez et al., Expression of the 67-kD laminin receptor, galectin-1, and galectin-3 in advanced human uterine adenocarcinoma, Hum Pathol, vol.27, pp.1185-1191, 1996.

I. Camby, N. Belot, S. Rorive, F. Lefranc, C. Maurage et al., Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and significantly modulate tumor astrocyte migration, Brain Pathol, vol.11, pp.12-26, 2001.

L. Astorgues-xerri, M. E. Riveiro, A. Tijeras-raballand, M. Serova, C. Neuzillet et al., Unraveling galectin-1 as a novel therapeutic target for cancer, Cancer Treat Rev, vol.40, pp.307-319, 2014.

J. M. Cousin and M. J. Cloninger, The role of galectin-1 in cancer progression, and synthetic multivalent systems for the study of galectin-1, Int J Mol Sci, vol.17, p.1566, 2016.

R. Bhat, B. Belardi, H. Mori, P. Kuo, A. Tam et al., Nuclear repartitioning of galectin-1 by an extracellular glycan switch regulates mammary morphogenesis, Proc Natl Acad Sci, vol.113, pp.4820-4827, 2016.

K. Shen, C. Li, L. Chien, C. Huang, C. Su et al., Role of galectin-1 in urinary bladder urothelial carcinoma cell invasion through the JNK pathway, Cancer Sci, vol.107, pp.1390-1398, 2016.

Y. Chong, D. Tang, Q. Xiong, X. Jiang, C. Xu et al., Galectin-1 from cancer-associated fibroblasts induces epithelial-mesenchymal transition through ?1 integrin-mediated upregulation of Gli1 in gastric cancer, J Exp Clin Cancer Res, vol.35, p.175, 2016.

Y. Chong, D. Tang, J. Gao, X. Jiang, C. Xu et al., Galectin-1 induces invasion and the epithelial-mesenchymal transition in human gastric cancer cells via non-canonical activation of the hedgehog signaling pathway, Oncotarget, vol.7, pp.83611-83626, 2016.

P. Zhang, K. Li, Y. H. Shen, P. Gao, Z. Dong et al., Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling, Cell Death Dis, vol.7, p.2201, 2016.

D. Qian, Z. Lu, Q. Xu, P. Wu, L. Tian et al., Galectin-1-driven upregulation of SDF-1 in pancreatic stellate cells promotes pancreatic cancer metastasis, Cancer Lett, vol.397, pp.43-51, 2017.

Y. Noda, M. Kishino, S. Sato, K. Hirose, M. Sakai et al., Galectin-1 expression is associated with tumour immunity and prognosis in gingival squamous cell carcinoma, J Clin Pathol, vol.70, pp.126-133, 2017.

L. Song, J. W. Tang, L. Owusu, M. Sun, J. Wu et al., Galectin-3 in cancer, Clin Chim Acta, vol.431, pp.185-191, 2014.

J. A. Ajani, J. S. Estrella, Q. Chen, A. M. Correa, L. Ma et al., Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors, Br J Cancer, vol.118, pp.52-61, 2018.

P. P. Ruvolo, Galectin 3 as a guardian of the tumor microenvironment, Biochim Biophys Acta, vol.1863, pp.427-437, 2016.

A. C. Cardoso, L. N. Andrade, S. O. Bustos, and R. Chammas, Galectin-3 determines tumor cell adaptive strategies in stressed tumor microenvironments, Front Oncol, vol.6, p.127, 2016.

A. Mackay, C. Jones, T. Dexter, R. L. Silva, K. Bulmer et al., cDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cells, Oncogene, vol.22, pp.2680-2688, 2003.

T. Nomura and N. Katunuma, Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells, J Med Invest, vol.52, pp.1-9, 2005.

D. Derocq, C. Prébois, M. Beaujouin, V. Laurent-matha, S. Pattingre et al., Cathepsin D is partly endocytosed by the LRP1 receptor and inhibits LRP1-regulated intramembrane proteolysis, Oncogene, vol.31, pp.3202-3212, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00646373

V. Dubey and S. Luqman, Cathepsin D as a promising target for the discovery of novel anticancer agents, Curr Cancer Drug Targets, vol.17, pp.404-422, 2017.

K. D. Brown, Transglutaminase 2 and NF-?B: An odd couple that shapes breast cancer phenotype, Breast Cancer Res Treat, vol.137, pp.329-336, 2013.

P. Yang, D. Yu, J. Zhou, S. Zhuang, and T. Jiang, TGM2 interference regulates the angiogenesis and apoptosis of colorectal cancer via Wnt/?-catenin pathway, Cell Cycle, vol.18, pp.1122-1134, 2019.

J. A. Eble and S. Niland, The extracellular matrix in tumor progression and metastasis, Clin Exp Metastasis, vol.36, pp.171-198, 2019.

N. Garamszegi, S. P. Garamszegi, L. A. Shehadeh, and S. P. Scully, Extracellular matrix-induced gene expression in human breast cancer cells, Mol Cancer Res, vol.7, pp.319-329, 2009.

K. Giehl and A. Menke, Microenvironmental regulation of E-cadherin-mediated adherens junctions, Front Biosci, vol.13, pp.3975-3985, 2008.

S. Yang, J. Shin, K. H. Park, H. Jeung, S. Y. Rha et al., Molecular basis of the differences between normal and tumor tissues of gastric cancer, Biochim Biophys Acta, vol.1772, pp.1033-1040, 2007.

Y. Liang, M. Diehn, A. W. Bollen, M. A. Israel, and N. Gupta, Type I collagen is overexpressed in medulloblastoma as a component of tumor microenvironment, J Neurooncol, vol.86, pp.133-141, 2008.

H. Montgomery, N. Rustogi, A. Hadjisavvas, K. Tanaka, K. Kyriacou et al., Proteomic profiling of breast tissue collagens and site-specific characterization of hydroxyproline residues of collagen alpha-1-(I), J Proteome Res, vol.11, pp.5890-5902, 2012.

A. Mitsuhashi, H. Goto, A. Saijo, V. T. Trung, Y. Aono et al., Fibrocyte-like cells mediate acquired resistance to anti-angiogenic therapy with bevacizumab, Nat Commun, vol.6, p.8792, 2015.

L. Rong, W. Huang, S. Tian, X. Chi, P. Zhao et al., COL1A2 is a novel biomarker to improve clinical prediction in human gastric cancer: Integrating bioinformatics and meta-analysis, Pathol Oncol Res, vol.24, pp.129-134, 2018.

X. Yang, E. D. Staren, J. M. Howard, T. Iwamura, J. E. Bartsch et al., Invasiveness and MMP expression in pancreatic carcinoma, J Surg Res, vol.98, pp.33-39, 2001.

M. Parmo-cabañas, I. Molina-ortiz, S. Matías-román, D. García-bernal, X. Vergara et al., Role of metalloproteinases MMP-9 and MT1-MMP in CXCL12-promoted myeloma cell invasion across basement membranes, J Pathol, vol.208, pp.108-118, 2006.

F. Ren, R. Tang, X. Zhang, W. M. Madushi, D. Luo et al., Overexpression of MMP family members functions as prognostic biomarker for breast cancer patients: A systematic review and meta-analysis, PLoS One, vol.10, p.135544, 2015.

H. Liu, W. Gu, C. Wang, J. , X. Mu et al., Matrix metalloproteinase-9 and -2 and tissue inhibitor of matrix metalloproteinase-2 in invasive pituitary adenomas: A systematic review and meta-analysis of case-control trials, Medicine (Baltimore), vol.95, p.3904, 2016.

G. S. Delassus, H. Cho, P. J. Eliceiri, G. Franco-barraza, J. Valdivia-silva et al., Actin cytoskeleton participation in the onset of IL-1beta induction of an invasive mesenchymal-like phenotype in epithelial MCF-7 cells, J Cell Physiol, vol.217, pp.170-181, 2008.

I. Matsuura, C. Lai, and K. Chiang, Functional interaction between Smad3 and S100A4 (metastatin-1) for TGF-beta-mediated cancer cell invasiveness, Biochem J, vol.426, pp.327-335, 2010.

T. Oskarsson, Extracellular matrix components in breast cancer progression and metastasis, Breast, vol.22, issue.2, pp.66-72, 2013.

R. N. Kaplan, R. D. Riba, S. Zacharoulis, A. H. Bramley, L. Vincent et al., VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche, Nature, vol.438, pp.820-827, 2005.

M. Topalovski and R. A. Brekken, Matrix control of pancreatic cancer: New insights into fibronectin signaling, Cancer Lett, vol.381, pp.252-258, 2016.

Y. Liao, Z. Zhang, J. Zhao, and J. Liu, Effects of fibronectin 1 on cell proliferation, senescence and apoptosis of human glioma cells through the PI3K/AKT signaling pathway, Cell Physiol Biochem, vol.48, pp.1382-1396, 2018.

S. Sercu, L. Zhang, and J. Merregaert, The extracellular matrix protein 1: Its molecular interaction and implication in tumor progression, Cancer Invest, vol.26, pp.375-384, 2008.

A. Bergamaschi, E. Tagliabue, T. Sørlie, B. Naume, T. Triulzi et al., Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome, J Pathol, vol.214, pp.357-367, 2008.

G. Lal, S. Hashimi, B. J. Smith, C. F. Lynch, L. Zhang et al., Extracellular matrix 1 (ECM1) expression is a novel prognostic marker for poor long-term survival in breast cancer: A Hospital-based Cohort Study in Iowa, Ann Surg Oncol, vol.16, pp.2280-2287, 2009.

K. M. Lee, K. Nam, S. Oh, J. Lim, R. K. Kim et al., ECM1 regulates tumor metastasis and CSC-like property through stabilization of ?-catenin, Oncogene, vol.34, pp.6055-6065, 2015.

H. Chen, J. W. Li, and J. , ECM1 promotes migration and invasion of hepatocellular carcinoma by inducing epithelial-mesenchymal transition, World J Surg Oncol, vol.14, p.195, 2016.

P. Gómez-contreras, R. , J. M. Sierra, A. Stipp, C. Domann et al., Extracellular matrix 1 (ECM1) regulates the actin cytoskeletal architecture of aggressive breast cancer cells in part via S100A4 and Rho-family GTPases, Clin Exp Metastasis, vol.34, pp.37-49, 2017.

L. Gan, J. Meng, M. Xu, M. Liu, Y. Qi et al., Extracellular matrix protein 1 promotes cell metastasis and glucose metabolism by inducing integrin ?4/FAK/SOX2/HIF-1? signaling pathway in gastric cancer, Oncogene, vol.37, pp.744-755, 2018.

S. Troup, C. Njue, E. V. Kliewer, M. Parisien, C. Roskelley et al., Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer, Clin Cancer Res, vol.9, pp.207-214, 2003.

B. Vuillermoz, A. Khoruzhenko, D. 'onofrio, M. Ramont, L. Venteo et al., The small leucine-rich proteoglycan lumican inhibits melanoma progression, Exp Cell Res, vol.296, pp.294-306, 2004.

A. Radwanska, M. Litwin, D. Nowak, D. Baczynska, Y. Wegrowski et al., Overexpression of lumican affects the migration of human colon cancer cells through up-regulation of gelsolin and filamentous actin reorganization, Exp Cell Res, vol.318, pp.2312-2323, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00780651

V. J. Coulson-thomas, Y. M. Coulson-thomas, T. F. Gesteira, A. De-paula, C. A. Carneiro et al., Lumican expression, localization and antitumor activity in prostate cancer, Exp Cell Res, vol.319, pp.967-981, 2013.

M. De-wit, B. Carvalho, P. M. Delis-van-diemen, C. Van-alphen, J. Beliën et al., Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression, PLoS One, vol.12, p.174768, 2017.

C. Farace, J. A. Oliver, C. Melguizo, P. Alvarez, P. Bandiera et al., Microenvironmental modulation of decorin and lumican in Temozolomide-resistant glioblastoma and neuroblastoma cancer stem-like cells, PLoS One, vol.10, p.134111, 2015.

A. Jeanne, V. Untereiner, C. Perreau, I. Proult, C. Gobinet et al., Lumican delays melanoma growth in mice and drives tumor molecular assembly as well as response to matrix-targeted TAX2 therapeutic peptide, Sci Rep, vol.7, p.7700, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02184436

P. G. Gritsenko, O. Ilina, and P. Friedl, Interstitial guidance of cancer invasion, J Pathol, vol.226, pp.185-199, 2012.

K. Ruan, B. S. Ouyang, and G. , The multifaceted role of periostin in tumorigenesis, Cell Mol Life Sci, vol.66, pp.2219-2230, 2009.

G. Kim, J. S. Lee, M. H. Park, and J. H. Yoon, Epithelial periostin expression is correlated with poor survival in patients with invasive breast carcinoma, PLoS One, vol.12, p.187635, 2017.

M. Mino, K. Kanno, K. Okimoto, A. Sugiyama, N. Kishikawa et al., Periostin promotes malignant potential by induction of epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma, Hepatol Commun, vol.1, pp.1099-1109, 2017.

B. Sid, H. Sartelet, G. Bellon, E. Btaouri, H. Rath et al., Thrombospondin 1: A multifunctional protein implicated in the regulation of tumor growth, Crit Rev Oncol Hematol, vol.49, pp.245-258, 2004.

K. Okada, K. Hirabayashi, T. Imaizumi, M. Matsuyama, N. Yazawa et al., Stromal thrombospondin-1 expression is a prognostic indicator and a new marker of invasiveness in intraductal papillary-mucinous neoplasm of the pancreas, Biomed Res, vol.31, pp.13-19, 2010.

V. Firlej, J. Mathieu, C. Gilbert, L. Lemonnier, J. Nakhlé et al., Thrombospondin-1 triggers cell migration and development of advanced prostate tumors, Cancer Res, vol.71, pp.7649-7658, 2011.

A. Radziwon-balicka, M. J. Santos-martinez, J. J. Corbalan, S. O'sullivan, A. Treumann et al., Mechanisms of platelet-stimulated colon cancer invasion: Role of clusterin and thrombospondin 1 in regulation of the P38MAPK-MMP-9 pathway, Carcinogenesis, vol.35, pp.324-332, 2014.

R. Joshi, E. Goihberg, W. Ren, M. Pilichowska, and P. Mathew, Proteolytic fragments of fibronectin function as matrikines driving the chemotactic affinity of prostate cancer cells to human bone marrow mesenchymal stromal cells via the ?5?1 integrin, Cell Adhes Migr, vol.11, pp.305-315, 2017.

S. Lebdai, G. Verhoest, H. Parikh, S. F. Jacquet, K. Bensalah et al., Identification and validation of TGFBI as a promising prognosis marker of clear cell renal cell carcinoma, Urol Oncol, vol.33, pp.69-80, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01064575

P. Nummela, J. Lammi, J. Soikkeli, O. Saksela, P. Laakkonen et al., Transforming growth factor beta-induced (TGFBI) is an anti-adhesive protein regulating the invasive growth of melanoma cells, Am J Pathol, vol.180, pp.1663-1674, 2012.

S. E. Klamer, C. G. Kuijk, P. L. Hordijk, C. E. Van-der-schoot, M. Von-lindern et al., BIGH3 modulates adhesion and migration of hematopoietic stem and progenitor cells, Cell Adhes Migr, vol.7, pp.434-449, 2013.

G. Kontostathi, J. Zoidakis, M. Makridakis, V. Lygirou, G. Mermelekas et al., Cervical cancer cell line secretome highlights the roles of transforming growth factor-beta-induced protein ig-h3, peroxiredoxin-2, and NRF2 on cervical carcinogenesis, BioMed Res Int, p.4180703, 2017.

R. A. Mathias, B. Wang, H. Ji, E. A. Kapp, R. L. Moritz et al., Secretome-based proteomic profiling of Ras-transformed MDCK cells reveals extracellular modulators of epithelial-mesenchymal transition, J Proteome Res, vol.8, pp.2827-2837, 2009.

P. C. Lunter, J. Van-kilsdonk, H. Van-beek, I. Cornelissen, M. Bergers et al., Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity, Cancer Res, vol.65, pp.8801-8808, 2005.

. Ofori-acquah, . Sf, and J. A. King, Activated leukocyte cell adhesion molecule: A new paradox in cancer, Transl Res, vol.151, pp.122-128, 2008.

U. H. Weidle, D. Eggle, S. Klostermann, and G. Swart, ALCAM/CD166: Cancer-related issues, Cancer Genomics Proteomics, vol.7, pp.231-243, 2010.

A. Von-lersner, L. Droesen, and A. Zijlstra, Modulation of cell adhesion and migration through regulation of the immunoglobulin superfamily member ALCAM/CD166, Clin Exp Metastasis, vol.36, pp.87-95, 2019.

A. Glentis, V. Gurchenkov, M. Vignjevic, and D. , Assembly, heterogeneity, and breaching of the basement membranes, Cell Adhes Migr, vol.8, pp.236-245, 2014.

A. Pozzi, P. D. Yurchenco, and R. V. Iozzo, The nature and biology of basement membranes, Matrix Biol, vol.57, pp.1-11, 2017.

M. J. Randles, M. J. Humphries, and R. Lennon, Proteomic definitions of basement membrane composition in health and disease, Matrix Biol, vol.57, pp.12-28, 2017.

Y. Zhou, Y. Zhu, X. Fan, C. Zhang, Y. Wang et al., NID1, a new regulator of EMT required for metastasis and chemoresistance of ovarian cancer cells, Oncotarget, vol.8, pp.33110-33121, 2017.

N. Pedrola, L. Devis, M. Llauradó, I. Campoy, E. Martinez-garcia et al., Nidogen 1 and Nuclear Protein 1: Novel targets of ETV5 transcription factor involved in endometrial cancer invasion, Clin Exp Metastasis, vol.32, pp.467-478, 2015.

B. Mcmahon and H. C. Kwaan, The plasminogen activator system and cancer, Pathophysiol Haemost Thromb, vol.36, pp.184-194, 2008.

M. Durand, J. S. Bødker, A. Christensen, D. M. Dupont, M. Hansen et al., Plasminogen activator inhibitor-I and tumour growth, invasion, and metastasis, Thromb Haemost, vol.91, pp.438-449, 2004.

R. T. Sitaram, P. Mallikarjuna, M. Landström, and B. Ljungberg, Transforming growth factor-? promotes aggressiveness and invasion of clear cell renal cell carcinoma, Oncotarget, vol.7, pp.35917-35931, 2016.

Z. A. Rabi, N. Todorovi?-rakovi?, T. Vujasinovi?, J. Milovanovi?, and . Nikoli?-vukosavljevi?, D: Markers of progression and invasion in short term follow up of untreated breast cancer patients, Cancer Biomark, vol.15, pp.745-754, 2015.

P. Rhone, B. Ruszkowska-ciastek, K. Bielawski, A. Brkic, E. Zarychta et al., Comprehensive analysis of haemostatic profile depending on clinicopathological determinants in breast cancer patients, Biosci Rep, vol.38, p.20171657, 2018.

S. Li, X. Wei, J. He, X. Tian, S. Yuan et al., Plasminogen activator inhibitor-1 in cancer research, Biomed Pharmacother, vol.105, pp.83-94, 2018.

J. Ochieng, G. Nangami, A. Sakwe, C. Moye, J. Alvarez et al., Impact of Fetuin-A (AHSG) on tumor progression and type 2 diabetes, Int J Mol Sci, vol.19, p.2211, 2018.

G. N. Nangami, K. Watson, K. Parker-johnson, K. O. Okereke, A. Sakwe et al., Fetuin-A (?2HS-glycoprotein) is a serum chemo-attractant that also promotes invasion of tumor cells through Matrigel, Biochem Biophys Res Commun, vol.438, pp.660-665, 2013.

K. Watson, R. Koumangoye, P. Thompson, A. M. Sakwe, T. Patel et al., Fetuin-A triggers the secretion of a novel set of exosomes in detached tumor cells that mediate their adhesion and spreading, FEBS Lett, vol.586, pp.3458-3463, 2012.

L. Niu, X. Song, N. Wang, L. Xue, X. Song et al., Tumor-derived exosomal proteins as diagnostic biomarkers in non-small cell lung cancer, Cancer Sci, vol.110, pp.433-442, 2019.

G. N. Adams, L. Rosenfeldt, M. Frederick, W. Miller, D. Waltz et al., Colon cancer growth and dissemination relies upon thrombin, stromal PAR-1, and fibrinogen, Cancer Res, vol.75, pp.4235-4243, 2015.

K. Honda, R. Asada, K. Kageyama, T. Fukuda, H. Terada et al., Protein complex of fibrinogen gamma chain and complement factor H in ovarian cancer patient plasma, Anticancer Res, vol.37, pp.2861-2866, 2017.

S. Duan, B. Gong, P. Wang, H. Huang, L. Luo et al., Novel prognostic biomarkers of gastric cancer based on gene expression microarray: COL12A1, GSTA3, FGA and FGG, Mol Med Rep, vol.18, pp.3727-3736, 2018.

X. Zhang, F. Wang, Y. Huang, K. Ke, B. Zhao et al., FGG promotes migration and invasion in hepatocellular carcinoma cells through activating epithelial to mesenchymal transition, Cancer Manag Res, vol.11, pp.1653-1665, 2019.

C. Brakebusch and R. Fässler, beta 1 integrin function in vivo: Adhesion, migration and more, Cancer Metastasis Rev, vol.24, pp.403-411, 2005.

B. Pan, J. Guo, Q. Liao, and Y. Zhao, ?1 and ?3 integrins in breast, prostate and pancreatic cancer: A novel implication

, Oncol Lett, vol.15, pp.5412-5416, 2018.

Q. Sun, C. Zhou, R. Ma, Q. Guo, H. Huang et al., Prognostic value of increased integrin-beta 1 expression in solid cancers: A meta-analysis, OncoTargets Ther, vol.11, pp.1787-1799, 2018.

T. Albrektsen, H. E. Richter, J. T. Clausen, and J. Fleckner, Identification of a novel integral plasma membrane protein induced during adipocyte differentiation, Biochem J, vol.359, pp.393-402, 2001.

A. R. Pessentheiner, K. Huber, H. J. Pelzmann, A. Prokesch, F. Radner et al., APMAP interacts with lysyl oxidase-like proteins, and disruption of Apmap leads to beneficial visceral adipose tissue expansion, FASEB J, vol.31, pp.4088-4103, 2017.

C. Gabriele, F. Cantiello, A. Nicastri, F. Crocerossa, G. I. Russo et al., High-throughput detection of low abundance sialylated glycoproteins in human serum by TiO 2 enrichment and targeted LC-MS/MS analysis: Application to a prostate cancer sample set, Anal Bioanal Chem, vol.411, pp.755-763, 2019.

S. Jiang, X. Wang, D. Song, X. Liu, Y. Gu et al., Cholesterol induces epithelial-to-mesenchymal transition of prostate cancer cells by suppressing degradation of EGFR through APMAP, Cancer Res, vol.79, pp.3063-3075, 2019.

M. Moriyama-kita, Y. Endo, Y. Yonemura, C. W. Heizmann, H. Miyamori et al., S100A4 regulates E-cadherin expression in oral squamous cell carcinoma, Cancer Lett, vol.230, pp.211-218, 2005.

J. Shin, I. Song, J. H. Pak, and S. Jang, Upregulation of annexin A1 expression by butyrate in human melanoma cells induces invasion by inhibiting E-cadherin expression, Tumour Biol, vol.37, pp.14577-14584, 2016.

S. Wong, C. M. Fang, L. Chuah, L. Co, and S. C. Ngai, E-cadherin: Its dysregulation in carcinogenesis and clinical implications, Crit Rev Oncol Hematol, vol.121, pp.11-22, 2018.

W. Yu, J. Wu, Z. L. Ning, Q. Y. Liu, and R. L. Quan, High expression of peroxiredoxin 1 is associated with epithelial-mesenchymal transition marker and poor prognosis in gastric cancer, Med Sci Monit, vol.24, pp.2259-2270, 2018.

S. Kim, Cancer energy metabolism: Shutting power off cancer factory, Biomol Ther (Seoul), vol.26, pp.39-44, 2018.

O. Warburg, K. Posener, and E. Negelein, Über den stoffwechsel der carcinomzelle, Biochem Zeitschr, vol.152, pp.309-344, 1924.

T. Chen, Z. Huang, Y. Tian, H. Wang, P. Ouyang et al., Role of triosephosphate isomerase and downstream functional genes on gastric cancer, Oncol Rep, vol.38, pp.1822-1832, 2017.

H. Lincet and P. Icard, How do glycolytic enzymes favour cancer cell proliferation by nonmetabolic functions?, Oncogene, vol.34, pp.3751-3759, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-01427176

S. N. Lone, R. Maqbool, F. Q. Parray, U. Hussain, and M. , Triose-phosphate isomerase is a novel target of miR-22 and miR-28, with implications in tumorigenesis, J Cell Physiol, vol.233, pp.8919-8929, 2018.

J. A. Menendez and R. Lupu, Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis, Nat Rev Cancer, vol.7, pp.763-777, 2007.

A. A. Madigan, K. J. Rycyna, A. V. Parwani, Y. J. Datiri, A. M. Basudan et al., Novel nuclear localization of fatty acid synthase correlates with prostate cancer aggressiveness, Am J Pathol, vol.184, pp.2156-2162, 2014.

H. Wang, Q. Xi, and G. Wu, Fatty acid synthase regulates invasion and metastasis of colorectal cancer via Wnt signaling pathway, Cancer Med, vol.5, pp.1599-1606, 2016.

S. Wen, Y. Niu, S. O. Lee, S. Yeh, Z. Shang et al., Targeting fatty acid synthase with ASC-J9 suppresses proliferation and invasion of prostate cancer cells, Mol Carcinog, vol.55, pp.2278-2290, 2016.

J. A. Menendez and R. Lupu, Fatty acid synthase (FASN) as a therapeutic target in breast cancer, Expert Opin Ther Targets, vol.21, pp.1001-1016, 2017.

N. Zaidi, J. V. Swinnen, and K. Smans, ATP-citrate lyase: A key player in cancer metabolism, Cancer Res, vol.72, pp.3709-3714, 2012.

Y. Cheng, B. Jia, W. Y. Wan, and S. , miR-133b acts as a tumor suppressor and negatively regulates ATP citrate lyase via PPAR? in gastric cancer, Oncol Rep, vol.38, pp.3220-3226, 2017.

C. Granchi and . Atp-citrate-lyase, ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism, Eur J Med Chem, vol.157, pp.1276-1291, 2018.

P. Icard and H. Lincet, The reduced concentration of citrate in cancer cells: An indicator of cancer aggressiveness and a possible therapeutic target, Drug Resist Updat, vol.29, pp.47-53, 2016.

A. Nicolussi, S. Inzeo, C. Capalbo, G. Giannini, and A. Coppa, The role of peroxiredoxins in cancer, Review) Mol Clin Oncol, vol.6, pp.139-153, 2017.

E. Veal, J. T. Latimer, and H. , Role/s of 'Antioxidant' enzymes in ageing, Subcell Biochem, vol.90, pp.425-450, 2018.

M. B. Hampton, K. A. Vick, J. J. Skoko, and C. A. Neumann, Peroxiredoxin involvement in the initiation and progression of human cancer, Antioxid Redox Signal, vol.28, pp.591-608, 2018.

S. W. Kang, L. S. Lee, and J. , Cancer-associated function of 2-Cys peroxiredoxin subtypes as a survival gatekeeper, Antioxidants, vol.7, p.161, 2018.

T. E. Forshaw, R. Holmila, K. J. Nelson, J. E. Lewis, M. L. Kemp et al., Peroxiredoxins in cancer and response to radiation therapies, vol.8, p.11, 2019.

E. Kim, S. Y. Lee, Y. Kim, S. Ahn, and H. H. Jang, Peroxiredoxin 1 post-transcriptionally regulates snoRNA expression, Free Radic Biol Med, vol.141, pp.1-9, 2019.

T. L. Dayton, T. Jacks, and M. G. Vander-heiden, PKM2, cancer metabolism, and the road ahead, EMBO Rep, vol.17, pp.1721-1730, 2016.

A. Méndez-lucas, X. Li, J. Hu, C. L. Song, X. Jia et al., Glucose catabolism in liver tumors induced by c-MYC can be sustained by various PKM1/PKM2 ratios and pyruvate kinase activities, Cancer Res, vol.77, pp.4355-4364, 2017.

Y. Zhao, E. B. Butler, and M. Tan, Targeting cellular metabolism to improve cancer therapeutics, Cell Death Dis, vol.4, p.532, 2013.

W. Zhou, L. A. Liotta, and E. F. Petricoin, Cancer metabolism and mass spectrometry-based proteomics, Cancer Lett, vol.356, pp.176-183, 2015.

T. Cheng, Y. , Y. Wang, H. Tien, Y. Shun et al., Pyruvate kinase M2 promotes pancreatic ductal adenocarcinoma invasion and metastasis through phosphorylation and stabilization of PAK2 protein, Oncogene, vol.37, pp.1730-1742, 2018.

S. A. Marchitti, C. Brocker, D. Stagos, and V. Vasiliou, Non-P450 aldehyde oxidizing enzymes: The aldehyde dehydrogenase superfamily, Expert Opin Drug Metab Toxicol, vol.4, pp.697-720, 2008.

X. Xu, S. Chai, P. Wang, C. Zhang, Y. Yang et al., Aldehyde dehydrogenases and cancer stem cells, Cancer Lett, vol.369, pp.50-57, 2015.

C. Zhou and B. Sun, The prognostic role of the cancer stem cell marker aldehyde dehydrogenase 1 in head and neck squamous cell carcinomas: A meta-analysis, Oral Oncol, vol.50, pp.1144-1148, 2014.

D. Wei, J. Peng, H. Gao, T. Zhang, T. Y. Hu et al., ALDH1 expression and the prognosis of lung cancer: A systematic review and meta-analysis, Heart Lung Circ, vol.24, pp.780-788, 2015.

J. Li, B. Zhang, Y. F. Yang, J. J. Liu, and Y. H. , Aldehyde dehydrogenase 1 as a predictor of the neoadjuvant chemotherapy response in breast cancer: A meta-analysis, Medicine (Baltimore), vol.97, p.12056, 2018.

M. Dvorakova, R. Nenutil, and P. Bouchal, Transgelins, cytoskeletal proteins implicated in different aspects of cancer development, Expert Rev Proteomics, vol.11, pp.149-165, 2014.

D. Rao, B. F. Kimler, W. B. Nothnick, M. K. Davis, F. F. Tawfik et al., Transgelin: A potentially useful diagnostic marker differentially expressed in triple-negative and non-triple-negative breast cancers, Hum Pathol, vol.46, pp.876-883, 2015.

V. Y. Tan, S. J. Lewis, A. J. Martin, and R. M. , Association of fascin-1 with mortality, disease progression and metastasis in carcinomas: A systematic review and meta-analysis, BMC Med, vol.11, p.52, 2013.

C. Iancu-rubin and G. F. Atweh, (Kip1) and stathmin share the stage for the first time, Trends Cell Biol, vol.15, pp.346-348, 2005.

B. Belletti and G. Baldassarre, Stathmin: A protein with many tasks. New biomarker and potential target in cancer, Expert Opin Ther Targets, vol.15, pp.1249-1266, 2011.

R. Biaoxue, L. Hua, G. Wenlong, and Y. Shuanying, Overexpression of stathmin promotes metastasis and growth of malignant solid tumors: A systemic review and meta-analysis, Oncotarget, vol.7, pp.78994-79007, 2016.

Z. Ding, Y. H. Bae, and P. Roy, Molecular insights on context-specific role of profilin-1 in cell migration, Cell Adhes Migr, vol.6, pp.442-449, 2012.

D. Alkam, E. Z. Feldman, A. Singh, and M. Kiaei, Profilin1 biology and its mutation, actin(g) in disease, Cell Mol Life Sci, vol.74, pp.967-981, 2017.

C. Jiang, Z. Ding, M. Joy, S. Chakraborty, S. H. Kim et al., A balanced level of profilin-1 promotes stemness and tumor-initiating potential of breast cancer cells, Cell Cycle, vol.16, pp.2366-2373, 2017.

Z. Wang, Z. Shi, L. Zhang, H. Zhang, and Y. Zhang, Profilin 1, negatively regulated by microRNA-19a-3p, serves as a tumor suppressor in human hepatocellular carcinoma, Pathol Res Pract, vol.215, pp.499-505, 2019.

F. Nakamura, T. P. Stossel, and J. H. Hartwig, The filamins: Organizers of cell structure and function, Cell Adhes Migr, vol.5, pp.160-169, 2011.

R. M. Savoy and P. M. Ghosh, The dual role of filamin A in cancer: Can't live with (too much of) it, can't live without it, Endocr Relat Cancer, vol.20, pp.341-356, 2013.

Q. Shao, T. Zhang, W. Zhao, Z. Liu, L. You et al., Filamin A: Insights into its exact role in cancers, vol.22, pp.245-252, 2016.

Y. Wang, S. Liu, Y. Zhang, and Y. J. , Myosin heavy chain 9: Oncogene or tumor suppressor gene?, Med Sci Monit, vol.25, pp.888-892, 2019.

M. Desouza-armstrong, G. Pw, and J. R. Stehn, Tumor suppressor tropomyosin Tpm2.1 regulates sensitivity to apoptosis beyond anoikis characterized by changes in the levels of intrinsic apoptosis proteins, Cytoskeleton (Hoboken), vol.74, pp.233-248, 2017.

Y. Ma, T. Xiao, Q. Xu, X. Shao, and H. Wang, iTRAQ-based quantitative analysis of cancer-derived secretory proteome reveals TPM2 as a potential diagnostic biomarker of colorectal cancer, Front Med, vol.10, pp.278-285, 2016.

J. Zhang, J. Zhang, S. Xu, X. Zhang, P. Wang et al., Hypoxia-induced TPM2 methylation is associated with chemoresistance and poor prognosis in breast cancer, Cell Physiol Biochem, vol.45, pp.692-705, 2018.

H. Shin, K. D. Helfman, and D. M. , Tropomyosin isoform Tpm2.1 regulates collective and amoeboid cell migration and cell aggregation in breast epithelial cells, Oncotarget, vol.8, pp.95192-95205, 2017.

C. B. Mitchell, B. Black, F. Sun, W. Chrzanowski, J. Cooper-white et al., Tropomyosin Tpm 2.1 loss induces glioblastoma spreading in soft brain-like environments, J Neurooncol, vol.141, pp.303-313, 2019.

S. Shishkin, L. Eremina, N. Pashintseva, L. Kovalev, and M. Kovaleva, Cofilin-1 and other ADF/Cofilin superfamily members in human malignant cells, Int J Mol Sci, vol.18, p.10, 2016.

A. N. Gasparski, S. Ozarkar, and K. A. Beningo, Transient mechanical strain promotes the maturation of invadopodia and enhances cancer cell invasion in vitro, J Cell Sci, vol.130, 1965.

C. Tsai, L. Lin, C. Wang, Y. Chiu, Y. Chou et al., Over-expression of cofilin-1 suppressed growth and invasion of cancer cells is associated with up-regulation of let-7 microRNA, Biochim Biophys Acta, vol.1852, pp.851-861, 2015.

M. Curto, A. Mcclatchey, and . Ezrin, a metastatic detERMinant?, Cancer Cell, vol.5, pp.113-114, 2004.

G. Haase, N. Gavert, T. Brabletz, and A. Ben-zé'ev, The Wnt target gene L1 in colon cancer invasion and metastasis, Cancers (Basel), vol.8, p.48, 2016.

Y. B. Cihan, Does ezrin play a predictive role in cancer patients undergoing radiotherapy and/or chemotherapy?, Hum Pathol, vol.80, pp.247-248, 2018.

C. T. Mierke, The role of vinculin in the regulation of the mechanical properties of cells, Cell Biochem Biophys, vol.53, pp.115-126, 2009.

W. H. Goldmann, V. Auernheimer, I. Thievessen, and B. Fabry, Vinculin, cell mechanics and tumour cell invasion, Cell Biol Int, vol.37, pp.397-405, 2013.

Y. Gao, Z. Wang, Q. Hao, W. Li, Y. Xu et al., Loss of ER? induces amoeboid-like migration of breast cancer cells by downregulating vinculin, Nat Commun, vol.8, p.14483, 2017.

E. Colombo, A. , M. Pelicci, and P. G. , Nucleophosmin and its complex network: A possible therapeutic target in hematological diseases, Oncogene, vol.30, pp.2595-2609, 2011.

J. S. Andersen, C. J. Wilkinson, T. Mayor, P. Mortensen, E. A. Nigg et al., Proteomic characterization of the human centrosome by protein correlation profiling, Nature, vol.426, pp.570-574, 2003.

J. K. Box, N. Paquet, M. N. Adams, D. Boucher, E. Bolderson et al., Nucleophosmin: From structure and function to disease development, BMC Mol Biol, vol.17, p.19, 2016.

M. T. Werner, C. Zhao, Q. Zhang, and M. A. Wasik, Nucleophosminanaplastic lymphoma kinase: The ultimate oncogene and therapeutic target, Blood, vol.129, pp.823-831, 2017.

A. Arrigo, Mammalian HspB1 (Hsp27) is a molecular sensor linked to the physiology and environment of the cell, Cell Stress Chaperones, vol.22, pp.517-529, 2017.

Y. Xie, L. Li, J. He, X. Xu, L. Liao et al., Heat shock protein family B member 1 facilitates ezrin activation to control cell migration in esophageal squamous cell carcinoma, Int J Biochem Cell Biol, vol.112, pp.79-87, 2019.

K. Honda, T. Yamada, R. Endo, Y. Ino, M. Gotoh et al., Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion, J Cell Biol, vol.140, pp.1383-1393, 1998.

Y. Hayashida, K. Honda, M. Idogawa, Y. Ino, M. Ono et al., E-cadherin regulates the association between beta-catenin and actinin-4, Cancer Res, vol.65, pp.8836-8845, 2005.

D. G. Thomas and D. N. Robinson, The fifth sense: Mechanosensory regulation of alpha-actinin-4 and its relevance for cancer metastasis, Semin Cell Dev Biol, vol.71, pp.68-74, 2017.

H. Yamaguchi, Y. Ito, N. Miura, Y. Nagamura, A. Nakabo et al., Actinin-1 and actinin-4 play essential but distinct roles in invadopodia formation by carcinoma cells, Eur J Cell Biol, vol.96, pp.685-694, 2017.

M. C. Keeling, L. R. Flores, A. H. Dodhy, M. E. Gavara, and N. , Actomyosin and vimentin cytoskeletal networks regulate nuclear shape, mechanics and chromatin organization, Sci, vol.7, p.5219, 2017.

R. A. Battaglia, S. Delic, H. H. Snider, and N. T. , Vimentin on the move: new developments in cell migration. F1000 Res 7 (F1000 Faculty Rev, p.1796, 2018.

J. Rao and N. Li, Microfilament actin remodeling as a potential target for cancer drug development, Curr Cancer Drug Targets, vol.4, pp.345-354, 2004.

E. Piktel, I. Levental, B. Durna?, P. A. Janmey, and R. Bucki, Plasma gelsolin: Indicator of inflammation and its potential as a diagnostic tool and therapeutic target, Int J Mol Sci, vol.19, p.2516, 2018.

S. Krishnakumar, A. Sundaram, D. Abhyankar, . Krishnamurthyv, M. P. Shanmugam et al., Major histocompatibility antigens and antigen-processing molecules in retinoblastoma, Cancer, vol.100, pp.1059-1069, 2004.

A. Okayama, Y. Miyagi, F. Oshita, M. Nishi, Y. Nakamura et al., Proteomic analysis of proteins related to prognosis of lung adenocarcinoma, J Proteome Res, vol.13, pp.4686-4694, 2014.

D. Ryan, S. Carberry, A. C. Murphy, A. U. Lindner, J. Fay et al., Calnexin, an ER stress-induced protein, is a prognostic marker and potential therapeutic target in colorectal cancer, J Transl Med, vol.14, 2016.

F. Vogiatzi, D. T. Brandt, J. Schneikert, J. Fuchs, K. Grikscheit et al., Mutant p53 promotes tumor progression and metastasis by the endoplasmic reticulum UDPase ENTPD5, Proc Natl Acad Sci, vol.113, pp.8433-8442, 2016.

Y. Chen, D. Ma, X. Wang, J. Fang, X. Liu et al., Calnexin impairs the antitumor immunity of CD4 + and CD8 + T cells, Cancer Immunol Res, vol.7, pp.123-135, 2018.

J. Dudek, J. Benedix, S. Cappel, M. Greiner, C. Jalal et al., Functions and pathologies of BiP and its interaction partners, Cell Mol Life Sci, vol.66, pp.1556-1569, 2009.

J. Wang, J. Lee, D. Liem, and P. P. , HSPA5 Gene encoding Hsp70 chaperone BiP in the endoplasmic reticulum, Gene, vol.618, pp.14-23, 2017.

M. K. Herroon, E. Rajagurubandara, J. D. Diedrich, E. I. Heath, and I. Podgorski, Adipocyte-activated oxidative and ER stress pathways promote tumor survival in bone via upregulation of Heme Oxygenase 1 and Survivin, Sci Rep, vol.8, p.40, 2018.

W. Chen, K. C. Do, B. Saxton, S. Leng, P. Filipczak et al., Inhibition of the hexosamine biosynthesis pathway potentiates cisplatin cytotoxicity by decreasing BiP expression in non-small-cell lung cancer cells, Mol Carcinog, vol.58, pp.1046-1055, 2019.

J. J. Sauk, N. Nikitakis, and H. Siavash, Hsp47 a novel collagen binding serpin chaperone, autoantigen and therapeutic target, Front Biosci, vol.10, pp.107-118, 2005.

B. Duarte and D. Bonatto, The heat shock protein 47 as a potential biomarker and a therapeutic agent in cancer research, J Cancer Res Clin Oncol, vol.144, pp.2319-2328, 2018.

S. Vatolin, J. G. Phillips, B. K. Jha, S. Govindgari, J. Hu et al., Novel protein disulfide isomerase inhibitor with anticancer activity in multiple myeloma, Cancer Res, vol.76, pp.3340-3350, 2016.

T. Kuo, T. Chen, S. Jiang, K. Chen, Y. Chiang et al., Protein disulfide isomerase a4 acts as a novel regulator of cancer growth through the procaspase pathway, Oncogene, vol.36, pp.5484-5496, 2017.

J. Fucikova, L. Kasikova, I. Truxova, J. Laco, P. Skapa et al., Relevance of the chaperone-like protein calreticulin for the biological behavior and clinical outcome of cancer, Immunol Lett, vol.193, pp.25-34, 2018.

W. Sheng, C. Chen, M. Dong, G. Wang, J. Zhou et al., Calreticulin promotes EGF-induced EMT in pancreatic cancer cells via Integrin/EGFR-ERK/MAPK signaling pathway, Cell Death Dis, vol.8, p.3147, 2017.

A. Schcolnik-cabrera, B. Oldak, M. Juárez, M. Cruz-rivera, A. Flisser et al., Calreticulin in phagocytosis and cancer: Opposite roles in immune response outcomes, Apoptosis, vol.24, pp.245-255, 2019.

C. Wang, J. G. , J. H. Wang, N. Luo, Q. Zhang et al., Clusterin facilitates metastasis by EIF3I/Akt/MMP13 signaling in hepatocellular carcinoma, Oncotarget, vol.6, pp.2903-2916, 2015.

B. Shapiro, P. Tocci, G. Haase, N. Gavert, and A. Ben-ze'ev, Clusterin, a gene enriched in intestinal stem cells, is required for L1-mediated colon cancer metastasis, Oncotarget, vol.6, pp.34389-34401, 2015.

Y. Liu, C. Men, Y. Xu, K. Zhao, L. Luo et al., Clusterin promotes growth and invasion of clear cell renal carcinoma cell by upregulation of S100A4 expression, Cancer Biomark, vol.21, pp.915-923, 2018.

K. D. Tew, Y. Manevich, C. Grek, Y. Xiong, J. Uys et al., The role of glutathione S-transferase P in signaling pathways and S-glutathionylation in cancer, Free Radic Biol Med, vol.51, pp.299-313, 2011.

Z. Wang, W. He, G. Yang, J. Wang, Z. Wang et al., Decreased expression of GST pi is correlated with a poor prognosis in human esophageal squamous carcinoma, BMC Cancer, vol.10, p.352, 2010.

M. Zannis-hadjopoulos, Y. W. Callejo, and M. , -3 cruciform-binding proteins as regulators of eukaryotic DNA replication, Trends Biochem Sci, vol.33, pp.44-50, 2008.

J. D. Bortner, A. Das, T. M. Umstead, W. M. Freeman, R. Somiari et al., Down-regulation of 14-3-3 isoforms and annexin A5 proteins in lung adenocarcinoma induced by the tobacco-specific nitrosamine NNK in the A/J mouse revealed by proteomic analysis, J Proteome Res, vol.8, pp.4050-4061, 2009.

M. F. Leal, D. Q. Calcagno, S. Demachki, P. P. Assumpção, R. Chammas et al., Clinical implication of 14-3-3 epsilon expression in gastric cancer, World J Gastroenterol, vol.18, pp.1531-1537, 2012.

Y. Qiu, Z. Zhou, Z. Li, L. Lu, L. Li et al., Pretreatment 14-3-3 epsilon level is predictive for advanced extranodal NK/T cell lymphoma therapeutic response to asparaginase-based chemotherapy, Proteomics Clin Appl, vol.11, pp.3-4, 2017.

A. Bavelloni, M. Piazzi, M. Raffini, I. Faenza, and W. L. Blalock, Prohibitin 2: At a communications crossroads, IUBMB Life, vol.67, pp.239-254, 2015.

S. Mishra and B. G. Nyomba, Prohibitin -At the crossroads of obesity-linked diabetes and cancer, Exp Biol Med (Maywood), vol.242, pp.1170-1177, 2017.

K. Taniguchi, K. Matsumura, S. Kageyama, H. Ii, E. Ashihara et al., Prohibitin-2 is a novel regulator of p21WAF1/CIP1 induced by depletion of ?-glutamylcyclotransferase, Biochem Biophys Res Commun, vol.496, pp.218-224, 2018.

Z. Zhou, H. Ai, K. Li, X. Yao, W. Zhu et al., Prohibitin 2 localizes in nucleolus to regulate ribosomal RNA transcription and facilitate cell proliferation in RD cells, Sci Rep, vol.8, p.1479, 2018.

Y. Shen, Y. Gao, H. Yuan, J. Cao, B. Jia et al., Prohibitin-2 negatively regulates AKT2 expression to promote prostate cancer cell migration, Int J Mol Med, vol.41, pp.1147-1155, 2018.

C. Yan, L. Gong, L. Chen, M. Xu, H. Abou-hamdan et al., PHB2 (prohibitin 2) promotes PI N K1-PR K N/ Pa rk in-dependent m itophagy by t he PARL-PGAM5-PINK1 axis, Autophagy, vol.16, pp.419-434, 2020.

R. Jubran, J. Kocsis, N. Garam, É. Maláti, T. Gombos et al., Circulating mitochondrial stress 70 protein/mortalin and cytosolic Hsp70 in blood: Risk indicators in colorectal cancer, Int J Cancer, vol.141, pp.2329-2335, 2017.

I. N. Cruz, H. M. Coley, H. B. Kramer, T. K. Madhuri, N. Safuwan et al., Proteomics analysis of ovarian cancer cell lines and tissues reveals drug resistance-associated proteins, Cancer Genomics Proteomics, vol.14, pp.35-51, 2017.

X. Niu, L. Su, S. Qi, Z. Gao, Q. Zhang et al., GRP75 modulates oncogenic Dbl-driven endocytosis derailed via the CHIP-mediated ubiquitin degradation pathway, Cell Death Dis, vol.9, p.971, 2018.

H. J. Chang, M. R. Lee, S. Hong, B. C. Yoo, Y. Shin et al., Identification of mitochondrial FoF1-ATP synthase involved in liver metastasis of colorectal cancer, Cancer Sci, vol.98, pp.1184-1191, 2007.

W. Kühlbrandt, Structure and mechanisms of F-type ATP synthases, Annu Rev Biochem, vol.88, pp.515-549, 2019.

J. Liu, X. Zhan, M. Li, G. Li, P. Zhang et al., Mitochondrial proteomics of nasopharyngeal carcinoma metastasis, BMC Med Genomics, vol.5, p.62, 2012.

W. Chen, K. Kuo, T. Chou, C. Chen, C. Wang et al., The role of cytochrome c oxidase subunit Va in non-small cell lung carcinoma cells: Association with migration, invasion and prediction of distant metastasis, BMC Cancer, vol.12, p.273, 2012.

Y. Wang, L. Hu, X. Zhang, H. Zhao, H. Xu et al., Downregulation of mitochondrial single stranded DNA binding protein (SSBP1) induces mitochondrial dysfunction and increases the radiosensitivity in non-small cell lung cancer cells, J Cancer, vol.8, pp.1400-1409, 2017.

A. Rajapakse, A. Suraweera, D. Boucher, A. Naqi, K. O'byrne et al., Redox Regulation in the Base Excision Repair Pathway: Old and New Players as Cancer Therapeutic Targets, Curr Med Chem, vol.27, 1901.

L. V. Croft, E. Bolderson, M. N. Adams, S. El-kamand, R. Kariawasam et al., Human single-stranded DNA binding protein 1 (hSSB1, OBFC2B), a critical component of the DNA damage response, Semin Cell Dev Biol, vol.86, pp.121-128, 2019.

M. Bozlu, D. Orhan, S. Baltaci, O. Yaman, A. H. Elhan et al., The prognostic value of proliferating cell nuclear antigen, Ki-67 and nucleolar organizer region in transitional cell carcinoma of the bladder, Int Urol Nephrol, vol.33, pp.59-66, 2002.

K. Maeda, Y. Chung, N. Onoda, M. Ogawa, Y. Kato et al., Association of tumor cell proliferation with lymph node metastasis in early gastric cancer, Oncology, vol.53, pp.1-5, 1996.

S. Ma, J. Yang, L. J. Song, and J. , The clinical utility of the proliferating cell nuclear antigen expression in patients with hepatocellular carcinoma, Tumour Biol, vol.37, pp.7405-7412, 2016.

L. Wang, W. Kong, B. Liu, and X. Zhang, Proliferating cell nuclear antigen promotes cell proliferation and tumorigenesis by up-regulating STAT3 in non-small cell lung cancer, Biomed Pharmacother, vol.104, pp.595-602, 2018.

K. Kato, S. Kawashiri, K. Yoshizawa, H. Kitahara, A. Okamune et al., Expression form of p53 and PCNA at the invasive front in oral squamous cell carcinoma: Correlation with clinicopathological features and prognosis, J Oral Pathol Med, vol.40, pp.693-698, 2011.

J. A. Dahl and P. Collas, Q2ChIP, a quick and quantitative chromatin immunoprecipitation assay, unravels epigenetic dynamics of developmentally regulated genes in human carcinoma cells, Stem Cells, vol.25, pp.1037-1046, 2007.

R. Mahen, H. Hattori, M. Lee, P. Sharma, A. D. Jeyasekharan et al., A-type lamins maintain the positional stability of DNA damage repair foci in mammalian nuclei, PLoS One, vol.8, p.61893, 2013.

K. M. Sakthivel and P. Sehgal, A novel role of lamins from genetic disease to cancer biomarkers, Oncol Rev, vol.10, p.309, 2016.

J. Kim, A. Louhghalam, G. Lee, B. W. Schafer, W. D. et al., Nuclear lamin A/C harnesses the perinuclear apical actin cables to protect nuclear morphology, Nat Commun, vol.8, p.2123, 2017.

F. Taheri, B. Isbilir, G. Müller, J. W. Krieger, G. Chirico et al., Random motion of chromatin is influenced by lamin A interconnections, Biophys J, vol.114, pp.2465-2472, 2018.

L. Zuo, H. Zhao, R. Yang, L. Wang, H. Ma et al., Lamin A/C might be involved in the EMT signalling pathway, Gene, vol.663, pp.51-64, 2018.

C. Dmello, S. S. Srivastava, R. Tiwari, P. R. Chaudhari, S. Sawant et al., Multifaceted role of keratins in epithelial cell differentiation and transformation, J Biosci, vol.44, p.33, 2019.

P. Sharma, S. Alsharif, A. Fallatah, and B. M. Chung, Intermediate filaments as effectors of cancer development and metastasis: A focus on keratins, vimentin, and nestin, Cells, vol.8, p.497, 2019.

J. A. Awe, J. Saranchuk, D. Drachenberg, and S. Mai, Filtration-based enrichment of circulating tumor cells from all prostate cancer risk groups, Urol Oncol, vol.35, pp.300-309, 2017.

A. Erlandsson, E. Forssell-aronsson, T. Seidal, and P. Bernhardt, Binding of TS1, an anti-keratin 8 antibody, in small-cell lung cancer after 177Lu-DOTA-Tyr3-octreotate treatment: A histological study in xenografted mice, EJNMMI Res, vol.1, p.19, 2011.

S. Sawant, M. Vaidya, D. Chaukar, P. Gangadaran, A. K. Singh et al., Clinicopathological features and prognostic implications of loss of K5 and gain of K1, K8 and K18 in oral potentially malignant lesions and squamous cell carcinomas: An immunohistochemical analysis, Edorium J Tumor Biol, vol.1, pp.1-22, 2014.

H. Alam, S. T. Kundu, D. Sn, and M. M. Vaidya, Loss of keratins 8 and 18 leads to alterations in ?6?4-integrin-mediated signalling and decreased neoplastic progression in an oral-tumour-derived cell line, J Cell Sci, vol.124, pp.2096-2106, 2011.

L. Sun and J. Fang, Epigenetic regulation of epithelial-mesenchymal transition, Cell Mol Life Sci, vol.73, pp.4493-4515, 2016.

B. Zhou and Y. Bai, Chromatin structures condensed by linker histones, Essays Biochem, vol.63, pp.75-87, 2019.

R. Sridharan, M. Gonzales-cope, C. Chronis, G. Bonora, R. Mckee et al., Proteomic and genomic approaches reveal critical functions of H3K9 methylation and heterochromatin protein-1? in reprogramming to pluripotency, Nat Cell Biol, vol.15, pp.872-882, 2013.

G. Tzivion, V. S. Gupta, L. Kaplun, and V. Balan, proteins as potential oncogenes, Semin Cancer Biol, vol.16, pp.203-213, 2006.

A. Kurpi?ska, J. Suraj, E. Bonar, A. Zakrzewska, M. Stojak et al., Proteomic characterization of early lung response to breast cancer metastasis in mice, Exp Mol Pathol, vol.107, pp.129-140, 2019.

T. Kawahara, N. Hotta, Y. Ozawa, S. Kato, K. Kano et al., Quantitative proteomic profiling identifies DPYSL3 as pancreatic ductal adenocarcinoma-associated molecule that regulates cell adhesion and migration by stabilization of focal adhesion complex, PLoS One, vol.8, p.79654, 2013.

R. Matsunuma, D. W. Chan, B. Kim, P. Singh, A. Han et al., DPYSL3 modulates mitosis, migration, and epithelial-to-mesenchymal transition in claudin-low breast cancer, Proc Natl Acad Sci, vol.115, pp.11978-11987, 2018.

Y. Yang, Y. Jiang, D. Xie, M. Liu, N. Song et al., Inhibition of cell-adhesion protein DPYSL3 promotes metastasis of lung cancer, Respir Res, vol.19, p.41, 2018.

P. Zarogoulidis, K. Tsakiridis, C. Karapantzou, S. Lampaki, I. Kioumis et al., Use of proteins as biomarkers and their role in carcinogenesis, J Cancer, vol.6, pp.9-18, 2015.

A. L. Frauchiger, R. Dummer, and J. Mangana, Serum S100B levels in melanoma, Methods Mol Biol, vol.1929, pp.691-700, 2019.

T. Yang, J. Cheng, J. You, B. Yan, H. Liu et al., S100B promotes chemoresistance in ovarian cancer stem cells by regulating p53, Oncol Rep, vol.40, pp.1574-1582, 2018.

A. Darlix, P. Lamy, E. Lopez-crapez, A. L. Braccini, N. Firmin et al., Serum HER2 extra-cellular domain, S100? and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients, BMC Cancer, vol.16, p.428, 2016.

H. Gao, I. Y. Zhang, L. Zhang, Y. Song, S. Liu et al., S100B suppression alters polarization of infiltrating myeloid-derived cells in gliomas and inhibits tumor growth, Cancer Lett, vol.439, pp.91-100, 2018.

M. Sadeghi, B. Ordway, I. Rafiei, P. Borad, B. Fang et al., Integrative analysis of breast cancer cells reveals an epithelial-mesenchymal transition role in adaptation to acidic microenvironment, Front Oncol, vol.10, p.304, 2020.

G. Pampalakis, E. Zingkou, K. G. Sidiropoulos, E. P. Diamandis, V. Zoumpourlis et al., Biochemical pathways mediated by KLK6 protease in breast cancer, Mol Oncol, vol.13, pp.2329-2343, 2019.

L. Seguella, R. Capuano, M. Pesce, G. Annunziata, M. Pesce et al., S100B protein stimulates proliferation and angiogenic mediators release through RAGE/pAkt/mTOR pathway in human colon adenocarcinoma Caco-2 cells, Int J Mol Sci, vol.20, p.3240, 2019.

O. Méndez, V. Peg, C. Salvans, M. Pujals, Y. Fernández et al., Extracellular HMGA1 promotes tumor invasion and metastasis in triple-negative breast cancer, Clin Cancer Res, vol.24, pp.6367-6382, 2018.

X. Wu, Y. Chen, C. Gong, and P. , The role of high-mobility group protein box 1 in lung cancer, J Cell Biochem, vol.119, pp.6354-6365, 2018.

A. K. Sharma, V. R. Sharma, G. K. Gupta, G. M. Ashraf, and M. A. Kamal, Advanced glycation end products (AGEs), glutathione and breast cancer: Factors, mechanism and therapeutic interventions, Curr Drug Metab, vol.20, pp.65-71, 2019.

D. Schröter and A. Höhn, Role of advanced glycation end products in carcinogenesis and their therapeutic implications, Curr Pharm Des, vol.24, pp.5245-5251, 2018.

G. Palanissami and S. Paul, RAGE and its ligands: Molecular interplay between glycation, inflammation, and hallmarks of cancer -a review, Horm Cancer, vol.9, pp.295-325, 2018.

S. Ahmad, H. Khan, Z. Siddiqui, M. Y. Khan, S. Rehman et al., RAGEs and s-RAGE; friend or foe for cancer, Semin Cancer Biol, vol.49, pp.44-55, 2018.

R. K. Thimmulappa, K. H. Mai, S. Srisuma, T. W. Kensler, M. Yamamoto et al., Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray, Cancer Res, vol.62, pp.5196-5203, 2002.

M. Sova and L. Saso, Design and development of Nrf2 modulators for cancer chemoprevention and therapy: A review, Drug Des Devel Ther, vol.12, pp.3181-3197, 2018.

K. Taguchi and M. Yamamoto, The KEAP1-NRF2 system in cancer, Front Oncol, vol.7, p.85, 2017.

R. De-la-vega, M. , C. E. Zhang, and D. D. , NRF2 and the hallmarks of cancer, Cancer Cell, vol.34, pp.21-43, 2018.

L. Lignitto, S. E. Leboeuf, H. Homer, S. Jiang, M. Askenazi et al., Nrf2 activation promotes lung cancer metastasis by inhibiting the degradation of Bach1, Cell, vol.178, pp.316-329, 2019.

C. Wiel, L. Gal, K. Ibrahim, M. X. Jahangir, C. A. Kashif et al., BACH1 stabilization by antioxidants stimulates lung cancer metastasis, vol.178, pp.330-345, 2019.

I. G. Ryoo, B. H. Choi, S. Ku, and K. , High CD44 expression mediates p62-associated NFE2L2/NRF2 activation in breast cancer stem cell-like cells: Implications for cancer stem cell resistance, Redox Biol, vol.17, pp.246-258, 2018.